Specialist
Former Senior Product Manager at Ping An Health Cloud Co Ltd
Agenda
- Internet hospitals competition and Ping An Good Doctor’s (HKG: 1833) cooperation model with hospitals, doctors and insurance companies
- Family doctor segment – revenue growth drivers and prospects
- Daily consultations, growth trends, user stickiness, monthly active users, payment rate and ARPU in the family doctor segment
- Medical insurance coverage of internet healthcare services and its impact
Questions
1.
Can you first share with us the development history and service offerings of Ping An Good Doctor’s family doctor segment? What are the development directions of the enterprise-oriented and customer-oriented business of the family doctor segment?
2.
With regard to the MAU and user traffic you just mentioned, the interim statements of Ping An Good Doctor in 2019 says that it has 2.229 million monthly paying users (MPUs), representing a YoY increase of 61.2%, while its annual report in 2018 listed an MPU of 2.36 million. Although its MPU YoY growth rate in 2019 is quite high, the actual number is lower than that in 2018. What’s the reason?
3.
Calculated based on other figures including MAU on its financial report, Ping An Good Doctor’s paying user conversion rate is around 3.56%, lower than that in 2018, 4.39%. Having a conversion rate of 3.56%, which competitive tier does it belong to?
4.
To attract more paying users, which business should Ping An Good Doctor pay more attention to?
5.
You have said that Ping An Good Doctor’s online consultation amount keeps increasing and may reach its ceiling so the platform intends to expand its Family Doctor business. There are indeed countless users consulting family doctors but how many paying users does this segment have? Will this segment continue to grow?
6.
The company’s current stratgy is focused on developing user habit for future benefits, rather than monetising the user traffic. Financial reports of Ping An Good Doctor released the revenue of the family doctor segment. Based on that revenue and the MPU of Ping An Good Doctor, it is calculated the ARPU of the family doctor segment in 2018 was less than RMB 20, while it was increased to RMB 20-30 by the middle of 2019. How did Ping An Good Doctor increase the ARPU? Can you brief us on its specific measures in the family doctor segment?
7.
Once again, let me explain that above-mentioned APRU is only a rough estimated average based on the data in Ping An Good Doctor’s financial reports, which cannot be regarded as accurate figure before further calculation. Let’s move on to other information. Ping An Good Doctor added the performance of AI segment into the financial report of 2018. The accumulated consultation is 400 million times involving over 3,000 kinds of diseases. Can you brief us on the function of AI-aided diagnosis in the family doctor segment, or relevant human resources and capital investment?
8.
The online consultation may involve the electronic prescriptions in later stages. Can you give an introduction to Ping An Good Doctor’s management and control model for related risks?
9.
The National Healthcare Security Administration is promoting the medical insurance coverage of internet healthcare services this year, which is of broad and current interest. It is said that the first draft for such policy has been completed. Do you think that such policy will influence Ping An Good Doctor’s family doctor segment?
10.
What’s the core competency of Ping An Good Doctor’s family doctor segment? Can other companies follow its model? Can the family doctor segment give Ping An Good Doctor competitive advantages?
11.
In addition to the family doctor segment, which business segments of Ping An Good Doctor have growth potential and deserve our attention?
Gain access to Premium Content
Submit your details to access up to 5 Forum Transcripts or to request a complimentary one week trial.
The information, material and content contained in this transcript (“Content”) is for information purposes only and does not constitute advice of any type or a trade recommendation and should not form the basis of any investment decision.This transcript has been edited by Third Bridge for ease of reading. Third Bridge Group Limited and its affiliates (together “Third Bridge”) make no representation and accept no liability for the Contentor for any errors, omissions or inaccuracies in respect of it. The views of the specialist expressed in the Content are those of the specialist and they are not endorsed by, nor do they represent the opinion of, Third Bridge. Third Bridge reserves all copyright, intellectual and other property rights in the Content. Any modification, reformatting, copying, displaying, distributing, transmitting, publishing, licensing, creating derivative works from, transferring or selling any Content is strictly prohibited
